Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1995
03/28/1995US5401507 Drug delivery
03/28/1995US5401498 Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use
03/28/1995CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response
03/28/1995CA2078214C Benzylphosphonic acid tyrosine kinase inhibitors
03/28/1995CA2029785C Glutaric acid derivatives and preparations thereof
03/28/1995CA2029046C Sustained release compositions for treating periodontal disease
03/28/1995CA1334977C Mono-iodopropargyl esters of dicarboxylic anhydrides and their use as antimicrobial agents
03/28/1995CA1334975C Furan and pyrrole containing lipoxygenase inhibiting compounds
03/28/1995CA1334973C Amine derivatives, processes for preparing the same and fungicides containing the same
03/28/1995CA1334972C Pyridine-2,4- and -2,5-dicarboxylic acid amides, processes for their preparation, the use thereof, and medicaments based on these compounds
03/28/1995CA1334970C Crystalline .beta.-lactam hydrate
03/28/1995CA1334969C Substituted dihydroisoquinoline and phthalazine derivatives as potentiators of the lethal effects of radiation and certain chemotherapeutic agents, selected compounds, analogs andprocess
03/28/1995CA1334968C Aminoalkylthio derivatives of triazolopyridine or triazoloquinoline, the processes for their preparation, and drugs, useful especially as analgesics, in which they are present
03/28/1995CA1334967C Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
03/28/1995CA1334949C Antimicrobial agent, fr 109615 and production thereof
03/28/1995CA1334935C Dithranol compositions
03/28/1995CA1334934C Antibacterial composition for oral administration
03/28/1995CA1334933C Pharmaceutical composition and process for its preparation
03/27/1995EP0660836A4 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds.
03/25/1995WO1999013871A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
03/25/1995CA2132794A1 Condensed 7-membered cyclic compounds and their use
03/25/1995CA2132792A1 Condensed cyclic compounds and their use
03/25/1995CA2132791A1 Azole compounds, their production and use
03/25/1995CA2132509A1 Treatment of anxiety with the aid of (s)-(-)-.alpha.- ethyl-2-oxo-1-pyrrolidineacetamide
03/24/1995CA2132579A1 Adhesion receptor antagonists iii
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007927A1 Androstenone derivative
03/23/1995WO1995007926A1 Androstenones
03/23/1995WO1995007925A1 Orally active derivatives of 1,3,5(10)-estratriene
03/23/1995WO1995007921A1 Chemical compounds, their preparation and use
03/23/1995WO1995007920A1 Nucleotide analogs
03/23/1995WO1995007919A1 Method for dosing therapeutic compounds
03/23/1995WO1995007918A2 Pyrimidine derivatives for labeled binding partners
03/23/1995WO1995007917A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
03/23/1995WO1995007911A1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY
03/23/1995WO1995007908A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
03/23/1995WO1995007906A1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
03/23/1995WO1995007905A1 Optically active imidazolidinone derivative and process for producing the same
03/23/1995WO1995007904A1 Imidazolone and oxazolone derivatives as dopamine antagonists
03/23/1995WO1995007903A1 Heterocyclic carboxamide derivatives with antiarrhythmic activity
03/23/1995WO1995007902A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
03/23/1995WO1995007901A1 Substituted tetronic acids useful for treating hiv and other retroviruses
03/23/1995WO1995007900A1 New cytotoxic agents
03/23/1995WO1995007899A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same
03/23/1995WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof
03/23/1995WO1995007894A1 Substituted pyridines and pyrimidines, process for producing them and their use as pesticides and fungicides
03/23/1995WO1995007893A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/23/1995WO1995007890A1 Substituted pyridines, process for producing them and their use as pesticides and fungicides
03/23/1995WO1995007886A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists
03/23/1995WO1995007885A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
03/23/1995WO1995007878A1 Novel compounds
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995WO1995007701A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
03/23/1995WO1995007700A1 Method for protection against genotoxic mutagenesis
03/23/1995WO1995007699A1 Novel method of progesterone delivery and affect thereof
03/23/1995WO1995007698A1 Trans platinum(iv) complexes
03/23/1995WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995WO1995007696A1 Pharmaceutical composition of hiv-protease inhibitors
03/23/1995WO1995007695A1 Method for inhibiting metalloproteinase expression
03/23/1995WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm
03/23/1995WO1995007692A1 Viscous surfactant emulsion compositions
03/23/1995WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
03/23/1995WO1995007690A1 Composition and method for treating nicotine craving in smoking cessation
03/23/1995WO1995007682A1 Oral compositions containing stannous compounds
03/23/1995WO1995005364A3 Inhibitors of biogenic amine transporters
03/23/1995WO1995005184A3 Phosphate-binding polymers for oral administration
03/23/1995WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
03/23/1995WO1994028908A3 (phospho)lipids for combatting hepatitis b virus infection
03/23/1995WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
03/23/1995DE4409671C1 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation
03/23/1995DE4332041A1 Use of pentoxifylline for the treatment of granulomatous and fibrotic pulmonary disorders
03/23/1995DE4331670A1 Antisense oligonucleotides against HSV-1 and the preparation thereof
03/23/1995CA2462061A1 Androstenone derivative
03/23/1995CA2172163A1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
03/23/1995CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995CA2171940A1 Chemical compounds, their preparation and use
03/23/1995CA2171868A1 Method for dosing therapeutic compounds
03/23/1995CA2171829A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
03/23/1995CA2171756A1 Succinamic acid compound, production method thereof and use thereof
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2170619A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
03/23/1995CA2168757A1 Substituted tetronic acids useful for treating hiv and other retroviruses
03/23/1995CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995CA2168740A1 Imidazolone and oxazolone derivatives as dopamine antagonists
03/23/1995CA2168739A1 Fused tricyclic heteroaromatic derivatives
03/23/1995CA2167412A1 Pharmaceutical composition of hiv-protease inhibitors
03/23/1995CA2132608A1 Pro-prodrugs, their production and use
03/23/1995CA2132568A1 Pharmaceutical compositions and usages
03/22/1995EP0644265A1 Antitumor agent
03/22/1995EP0644199A1 Cyclic antimicrobial peptides and preparation thereof
03/22/1995EP0644198A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors
03/22/1995EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
03/22/1995EP0644194A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof
03/22/1995EP0644192A1 A process for making a benzothiadiazole derivative
03/22/1995EP0644188A1 Process for the preparation of sulfur derivatives of imidazole and intermediates obtained
03/22/1995EP0644187A1 Antimigraine cyclobutenedione derivatives of tryptamines
03/22/1995EP0644182A1 Cyclohexane derivatives useful as potassium channel openers
03/22/1995EP0644181A1 Amino acid derivative and use thereof
03/22/1995EP0643970A2 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans
1 ... 7032 7033 7034 7035 7036 7037 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 7051 7052 ... 7860